Lactobacillus delbrueckii bulgaricus Completed Phase 4 Trials for Diarrhoea Predominant Irritable Bowel Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04053790
Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)